CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
27 hedge funds and large institutions have $4.82M invested in Carisma Therapeutics in 2016 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
58% less capital invested
Capital invested by funds: $11.5M → $4.82M (-$6.73M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $22K
Holders
27
Holding in Top 10
1
Calls
–
Puts
$22K
Top Buyers
| 1 | +$343K | |
| 2 | +$268K | |
| 3 | +$120K | |
| 4 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
+$65.5K |
| 5 |
EGA
Eagle Global Advisors
Houston,
Texas
|
+$41K |
Top Sellers
| 1 | -$2.1M | |
| 2 | -$1.97M | |
| 3 | -$222K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$130K |
| 5 |
DTL
Dynamic Technology Lab
Singapore
|
-$116K |